KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Evolent Health (EVH) Return on Equity (2016 - 2025)

Historic Return on Equity for Evolent Health (EVH) over the last 11 years, with Q3 2025 value amounting to 0.15%.

  • Evolent Health's Return on Equity fell 1100.0% to 0.15% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.15%, marking a year-over-year decrease of 1100.0%. This contributed to the annual value of 0.0% for FY2022, which is 100.0% up from last year.
  • As of Q3 2025, Evolent Health's Return on Equity stood at 0.15%, which was down 1100.0% from 0.14% recorded in Q2 2025.
  • Over the past 5 years, Evolent Health's Return on Equity peaked at 0.0% during Q4 2022, and registered a low of 0.15% during Q3 2025.
  • Its 5-year average for Return on Equity is 0.04%, with a median of 0.02% in 2024.
  • In the last 5 years, Evolent Health's Return on Equity skyrocketed by 3100bps in 2021 and then tumbled by -1300bps in 2025.
  • Over the past 5 years, Evolent Health's Return on Equity (Quarter) stood at 0.01% in 2021, then skyrocketed by 95bps to 0.0% in 2022, then tumbled by -3320bps to 0.02% in 2023, then crashed by -228bps to 0.06% in 2024, then plummeted by -144bps to 0.15% in 2025.
  • Its Return on Equity was 0.15% in Q3 2025, compared to 0.14% in Q2 2025 and 0.11% in Q1 2025.